Semaglutide, marketed as Ozempic and Wegovy, works as a single GLP-1 receptor agonist and typically produces weight loss of 15-20% of body weight over 12-18 months
Instead of three large meals, try five or six smaller portions throughout the day
However, bioavailability differs between administration routes, and semaglutide troches may require different dosing protocols than injectable forms
Patients should be counseled that some degree of hunger is normal and does not necessarily indicate treatment failure
It mimics the incretin hormone, which enhances insulin secretion, reduces glucagon release, and slows gastric emptying
The medication should be kept away from heat-generating appliances, including ovens, stoves, dishwashers, and electronic devices that produce heat during operation